Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists

Details for Australian Patent Application No. 2006328551 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Andres-Gil, Jose Ignacio; Vega Ramiro, Juan Antonio; Drinkenburg, Wilhelmus Helena Ignatius Maria; Alcazar-Vaca, Manuel Jesus; Linares De La Morena, Maria Lourdes; Pastor-Fernandez, Joaquin; Oyarzabal Santamarina, Julen; Martinez Gonzalez, Sonia

Agent Shelston IP

Pub. Number AU-A-2006328551

PCT Pub. Number WO2007/071639

Priority 05112646.4 21.12.05 EP

Filing date 18 December 2006

Wipo publication date 28 June 2007

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/497 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/071639 Priority application(s): WO2007/071639

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328558-Novel substituted pyrazinone derivatives for use in MCH-1 mediated diseases

2006328550-Compounds with medicinal effects due to interaction with the glucocorticoid receptor